These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 21085046)

  • 1. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
    Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
    Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET and CT characterization of adrenal lesions in cancer patients.
    Jana S; Zhang T; Milstein DM; Isasi CR; Blaufox MD
    Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):29-35. PubMed ID: 16193311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT in the evaluation of adrenal masses.
    Metser U; Miller E; Lerman H; Lievshitz G; Avital S; Even-Sapir E
    J Nucl Med; 2006 Jan; 47(1):32-7. PubMed ID: 16391184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
    Yun M; Kim W; Alnafisi N; Lacorte L; Jang S; Alavi A
    J Nucl Med; 2001 Dec; 42(12):1795-9. PubMed ID: 11752075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.
    Hickeson M; Yun M; Matthies A; Zhuang H; Adam LE; Lacorte L; Alavi A
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1639-47. PubMed ID: 12458399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.
    Wumener X; Zhang Y; Zang Z; Du F; Ye X; Zhang M; Liu M; Zhao J; Sun T; Liang Y
    BMC Pulm Med; 2024 May; 24(1):227. PubMed ID: 38730287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas.
    Nakamoto Y; Higashi T; Sakahara H; Tamaki N; Kogire M; Doi R; Hosotani R; Imamura M; Konishi J
    Cancer; 2000 Dec; 89(12):2547-54. PubMed ID: 11135214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of
    Zhang Y; Han J; Li J; Cao J; Zhou Y; Deng S; Zhang B; Yang Y
    J Cancer Res Clin Oncol; 2024 May; 150(5):265. PubMed ID: 38769201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
    Namura K; Minamimoto R; Yao M; Makiyama K; Murakami T; Sano F; Hayashi N; Tateishi U; Ishigaki H; Kishida T; Miura T; Kobayashi K; Noguchi S; Inoue T; Kubota Y; Nakaigawa N
    BMC Cancer; 2010 Dec; 10():667. PubMed ID: 21129184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer.
    Khan N; Oriuchi N; Yoshizaki A; Kanuma T; Higuchi T; Endo K
    Ann Nucl Med; 2005 Apr; 19(2):137-45. PubMed ID: 15909494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic usefulness of FDG PET for pancreatic mass lesions.
    Koyama K; Okamura T; Kawabe J; Nakata B; Chung KH; Ochi H; Yamada R
    Ann Nucl Med; 2001 Jun; 15(3):217-24. PubMed ID: 11545191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.
    Sperti C; Pasquali C; Decet G; Chierichetti F; Liessi G; Pedrazzoli S
    J Gastrointest Surg; 2005 Jan; 9(1):22-8; discussion 28-9. PubMed ID: 15623441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorodeoxyglucose-positron-emission tomography/computed tomography imaging for adrenal masses in patients with lung cancer: review and diagnostic algorithm.
    Stone WZ; Wymer DC; Canales BK
    J Endourol; 2014 Jan; 28(1):104-11. PubMed ID: 23927734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of benign vs malignant hepatic lesions with positron emission tomography.
    Delbeke D; Martin WH; Sandler MP; Chapman WC; Wright JK; Pinson CW
    Arch Surg; 1998 May; 133(5):510-5; discussion 515-6. PubMed ID: 9605913
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Cao L; Zhang D; Yang H; Xu W; Liu Y
    World J Surg Oncol; 2023 Sep; 21(1):305. PubMed ID: 37749562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET.
    Khan N; Oriuchi N; Ninomiya H; Higuchi T; Kamada H; Endo K
    Ann Nucl Med; 2004 Jul; 18(5):409-17. PubMed ID: 15462403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors.
    Tsatalpas P; Beuthien-Baumann B; Kropp J; Manseck A; Tiepolt C; Hakenberg OW; Burchert W; Franke WG; Wirth MP
    Urol Int; 2002; 68(3):157-63. PubMed ID: 11919460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Fluorine18 Fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computed Tomography in Metabolic Characterization of Solid Renal Mass Lesion and Localization of Extra Renal Lesions in the Body - A Prospective Study from the Tertiary Care Center in South India.
    Sri Charan KB; Kalawat T; Priya RR; Nallabothula AK; Manthri RG; Reddy SC; Narendra H; Rukmangadha N; Kale PKG; Ajit N
    Indian J Nucl Med; 2022; 37(4):329-336. PubMed ID: 36817204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.
    BĂ©nard F; Sterman D; Smith RJ; Kaiser LR; Albelda SM; Alavi A
    Chest; 1998 Sep; 114(3):713-22. PubMed ID: 9743156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.